These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26784148)

  • 1. ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.
    Barresi V; Spampinato G; Musso N; Trovato Salinaro A; Rizzarelli E; Condorelli DF
    J Inorg Biochem; 2016 Mar; 156():145-52. PubMed ID: 26784148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper chaperone Atox1 plays role in breast cancer cell migration.
    Blockhuys S; Wittung-Stafshede P
    Biochem Biophys Res Commun; 2017 Jan; 483(1):301-304. PubMed ID: 28027931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiol-based copper handling by the copper chaperone Atox1.
    Hatori Y; Inouye S; Akagi R
    IUBMB Life; 2017 Apr; 69(4):246-254. PubMed ID: 28294521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
    Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
    Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells.
    Cai H; Peng F
    Oncol Rep; 2013 Jul; 30(1):269-75. PubMed ID: 23624903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved residues modulate copper release in human copper chaperone Atox1.
    Hussain F; Olson JS; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11158-63. PubMed ID: 18685091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
    Brose J; La Fontaine S; Wedd AG; Xiao Z
    Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
    Xi Z; Guo W; Tian C; Wang F; Liu Y
    Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion.
    Mangini V; Belviso BD; Nardella MI; Natile G; Arnesano F; Caliandro R
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.
    Chen GF; Sudhahar V; Youn SW; Das A; Cho J; Kamiya T; Urao N; McKinney RD; Surenkhuu B; Hamakubo T; Iwanari H; Li S; Christman JW; Shantikumar S; Angelini GD; Emanueli C; Ushio-Fukai M; Fukai T
    Sci Rep; 2015 Oct; 5():14780. PubMed ID: 26437801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
    Öhrvik H; Wittung-Stafshede P
    Int J Mol Sci; 2015 Jul; 16(8):16728-39. PubMed ID: 26213915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
    Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
    Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
    Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
    Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
    Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
    Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved residue modulates copper-binding properties through structural dynamics in human copper chaperone Atox1.
    Xi Z; Shi C; Tian C; Liu Y
    Metallomics; 2013 Nov; 5(11):1566-73. PubMed ID: 24056613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
    Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone atox1 in aqueous solution.
    Calandrini V; Nguyen TH; Arnesano F; Galliani A; Ippoliti E; Carloni P; Natile G
    Chemistry; 2014 Sep; 20(37):11719-25. PubMed ID: 25111319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organization of ATOX1, a human copper chaperone.
    Liu PC; Koeller DM; Kaler SG
    BMC Genet; 2003 Feb; 4():4. PubMed ID: 12594858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1.
    Itoh S; Ozumi K; Kim HW; Nakagawa O; McKinney RD; Folz RJ; Zelko IN; Ushio-Fukai M; Fukai T
    Free Radic Biol Med; 2009 Jan; 46(1):95-104. PubMed ID: 18977292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro.
    Kahra D; Mondol T; Niemiec MS; Wittung-Stafshede P
    Protein Pept Lett; 2015; 22(6):532-8. PubMed ID: 25962064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.